Posted On: 06/15/2014 10:58:43 AM
Post# of 74553
$ACT News
10 best-performing S&P 500 stocks of 2014 2:38 p.m. June 2, 2014 - Philip van Doorn
Pfizer's plan to relocate after merger deal draws lawmakers' fire 11:30 a.m. May 9, 2014 - Russ Britt
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
Mylan to start selling generic Celebrex in May 7:23 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - Russ Britt
Staples awash in red; eBay up as Icahn posts new letter 5:09 p.m. March 6, 2014 - Sue Chang
Icahn Enterprises reports profit up 144% in 2013 11:23 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 12:12 p.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 5:46 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 6:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 12:21 p.m. Feb. 20, 2014 - Russ Britt
Actavis swings to loss on charges, write-downs 9:04 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 2:59 p.m. Feb. 19, 2014 - Russ Britt
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 12:03 p.m. Feb. 19, 2014 - Russ Britt
U.S. stocks edge up; Nasdaq gains for 8th day in a row 5:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 5:11 p.m. Feb. 18, 2014 - Sue Chang
Actavis Strives To Reduce Borrowing Costs 5:00 p.m. June 13, 2014 - Investors Business Daily
Vivus Suit Preserves Exclusivity Of Qsymia - For Now 2:56 p.m. June 13, 2014 - Seeking Alpha
Will Forest Labs Retain Namenda Market Share? - Analyst Blog 12:00 p.m. June 13, 2014 - Zacks.com
Vivus sues Actavis 5:59 p.m. June 12, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – EXAM ACT FRX ACOR 2:00 p.m. June 11, 2014 - InvestorPlace.com
Today's Top Performers In Health Care 1:03 p.m. June 11, 2014 - TheStreet.com
Allergan loses patent appeal 6:46 a.m. June 11, 2014 - Seeking Alpha
Actavis, BitAuto Among Leading World Stocks In Bases 5:50 p.m. June 10, 2014 - Investors Business Daily
Lannett In Buying Range After Breakout From Cup Base 3:35 p.m. June 10, 2014 - Investors Business Daily
Actavis offers new unsecured debt 12:20 p.m. June 10, 2014 - Seeking Alpha
Several IBD 50 Names Set Up In Stock Picker's Market 4:58 p.m. June 6, 2014 - Investors Business Daily
3 Stocks Moving The Drugs Industry Upward 1:03 p.m. June 6, 2014 - TheStreet.com
More Stock Leaders Emerge From More Industry Groups 5:03 p.m. June 5, 2014 - Investors Business Daily
Top New Buys: Funds Pile Into Actavis, chip stocks 5:35 p.m. June 3, 2014 - Investors Business Daily
Actavis Acquires Forest Labs For Brand-Name Drugs 5:03 p.m. June 2, 2014 - Investors Business Daily
Actavis and Cephalon settle patent fight 4:35 p.m. May 30, 2014 - Seeking Alpha
Actavis Announces Nuvigil Patent Challenge Settlement 3:05 p.m. May 30, 2014 - benzinga.com
Many Weekly Review Stocks Still Nearing Buy Points 5:50 p.m. May 29, 2014 - Investors Business Daily
Actavis, Forest CEOs Team Up To Lead New Drug Giant 3:47 p.m. May 29, 2014 - Investors Business Daily
Oakmark Funds' Bill Nygren Buys 4 New Stocks 2:38 p.m. May 29, 2014 - GuruFocus.com
Actavis Announces Receipt of Requisite Consents and Expiration of Consent Solicitations for Forest Laboratories Senior Notes 6:16 p.m. June 12, 2014 - PR Newswire - PRF
Forest Laboratories, Inc. Announces Receipt of Requisite Consents and Expiration of Consent Solicitations for Certain of its Senior Notes 5:00 p.m. June 12, 2014 - BusinessWire - BZX
VIVUS Files Lawsuit Against Actavis for Infringement of Qsymia Patents 4:33 p.m. June 12, 2014 - Marketwire
Actavis Prices $3.7 Billion of Senior Unsecured Notes 5:19 p.m. June 10, 2014 - PR Newswire - PRF
Fitch Rates New Actavis Bonds 'BBB-'; Outlook Stable 10:55 a.m. June 10, 2014 - BusinessWire - BZX
Actavis Announces Offering of Senior Unsecured Notes 8:48 a.m. June 10, 2014 - PR Newswire - PRF
Actavis Finalizes Agreement Related to Asacol® HD Patent Challenge Litigation 5:54 p.m. June 9, 2014 - PR Newswire - PRF
Forest Laboratories, Inc. Extends Expiration Time of Consent Solicitations to Eliminate Existing Registration Rights Obligations on Certain of its Senior Notes 8:03 a.m. June 9, 2014 - BusinessWire - BZX
Actavis Extends Expiration Time of Offer to Guarantee Certain Forest Laboratories Senior Notes in Connection with Forest Consent Solicitations 8:00 a.m. June 9, 2014 - PR Newswire - PRF
Health Care Sector Equities Scrutiny -- Research on AVANIR Pharma, Zoetis, Actavis, and Mallinckrodt 7:50 a.m. June 3, 2014 - PR Newswire - PRF
New Employers Listed For Annual Life Science Hiring Event 10:45 a.m. June 2, 2014 - PR Newswire - PRF
Actavis Announces Nuvigil® Patent Challenge Settlement 4:05 p.m. May 30, 2014 - PR Newswire - PRF
Enzo Biochem Announces Appointment of James M. O’Brien as Senior VP, Finance 9:01 a.m. May 30, 2014 - BusinessWire - BZX
Breakthrough Innovation for Animal Health, Upcoming Conference Presentations, and New Treatment Options for Patients - Analyst Notes on Merck, Actavis, Celgene, Bristol-Myers Squibb and GSK 5:50 a.m. May 29, 2014 - PR Newswire - PRF
Actavis Confirms Generic Onglyza® Patent Challenge 4:05 p.m. May 27, 2014 - PR Newswire - PRF
Forest Laboratories, Inc. Commences Consent Solicitations to Eliminate Existing Registration Rights Obligations on Certain of its Senior Notes 8:31 a.m. May 22, 2014 - BusinessWire - BZX
Actavis Offers to Guarantee Certain Forest Laboratories Senior Notes in connection with Forest Consent Solicitations 8:30 a.m. May 22, 2014 - PR Newswire - PRF
Study Results, Extension of Supply Agreements, Drug Designations, Senior Level Appointments, and Upcoming Events - Analyst Notes on InterMune, Actavis, Bristol-Myers, AbbVie and Illumina 8:30 a.m. May 22, 2014 - PR Newswire - PRF
Actavis to Present at Goldman Sachs 35th Annual Global Healthcare Conference 2014 8:00 a.m. May 21, 2014 - PR Newswire - PRF
FDA Approvals, Stock Price Updates, and Financial Results Release - Analyst Notes on Pfizer, Actavis, Pharmacyclics, Mallinckrodt and Salix Pharmaceuticals 7:40 a.m. May 16, 2014 - PR Newswire - PRF
10 best-performing S&P 500 stocks of 2014 2:38 p.m. June 2, 2014 - Philip van Doorn
Pfizer's plan to relocate after merger deal draws lawmakers' fire 11:30 a.m. May 9, 2014 - Russ Britt
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
Mylan to start selling generic Celebrex in May 7:23 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - Russ Britt
Staples awash in red; eBay up as Icahn posts new letter 5:09 p.m. March 6, 2014 - Sue Chang
Icahn Enterprises reports profit up 144% in 2013 11:23 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 12:12 p.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 5:46 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 6:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 12:21 p.m. Feb. 20, 2014 - Russ Britt
Actavis swings to loss on charges, write-downs 9:04 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 2:59 p.m. Feb. 19, 2014 - Russ Britt
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 12:03 p.m. Feb. 19, 2014 - Russ Britt
U.S. stocks edge up; Nasdaq gains for 8th day in a row 5:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 5:11 p.m. Feb. 18, 2014 - Sue Chang
Actavis Strives To Reduce Borrowing Costs 5:00 p.m. June 13, 2014 - Investors Business Daily
Vivus Suit Preserves Exclusivity Of Qsymia - For Now 2:56 p.m. June 13, 2014 - Seeking Alpha
Will Forest Labs Retain Namenda Market Share? - Analyst Blog 12:00 p.m. June 13, 2014 - Zacks.com
Vivus sues Actavis 5:59 p.m. June 12, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – EXAM ACT FRX ACOR 2:00 p.m. June 11, 2014 - InvestorPlace.com
Today's Top Performers In Health Care 1:03 p.m. June 11, 2014 - TheStreet.com
Allergan loses patent appeal 6:46 a.m. June 11, 2014 - Seeking Alpha
Actavis, BitAuto Among Leading World Stocks In Bases 5:50 p.m. June 10, 2014 - Investors Business Daily
Lannett In Buying Range After Breakout From Cup Base 3:35 p.m. June 10, 2014 - Investors Business Daily
Actavis offers new unsecured debt 12:20 p.m. June 10, 2014 - Seeking Alpha
Several IBD 50 Names Set Up In Stock Picker's Market 4:58 p.m. June 6, 2014 - Investors Business Daily
3 Stocks Moving The Drugs Industry Upward 1:03 p.m. June 6, 2014 - TheStreet.com
More Stock Leaders Emerge From More Industry Groups 5:03 p.m. June 5, 2014 - Investors Business Daily
Top New Buys: Funds Pile Into Actavis, chip stocks 5:35 p.m. June 3, 2014 - Investors Business Daily
Actavis Acquires Forest Labs For Brand-Name Drugs 5:03 p.m. June 2, 2014 - Investors Business Daily
Actavis and Cephalon settle patent fight 4:35 p.m. May 30, 2014 - Seeking Alpha
Actavis Announces Nuvigil Patent Challenge Settlement 3:05 p.m. May 30, 2014 - benzinga.com
Many Weekly Review Stocks Still Nearing Buy Points 5:50 p.m. May 29, 2014 - Investors Business Daily
Actavis, Forest CEOs Team Up To Lead New Drug Giant 3:47 p.m. May 29, 2014 - Investors Business Daily
Oakmark Funds' Bill Nygren Buys 4 New Stocks 2:38 p.m. May 29, 2014 - GuruFocus.com
Actavis Announces Receipt of Requisite Consents and Expiration of Consent Solicitations for Forest Laboratories Senior Notes 6:16 p.m. June 12, 2014 - PR Newswire - PRF
Forest Laboratories, Inc. Announces Receipt of Requisite Consents and Expiration of Consent Solicitations for Certain of its Senior Notes 5:00 p.m. June 12, 2014 - BusinessWire - BZX
VIVUS Files Lawsuit Against Actavis for Infringement of Qsymia Patents 4:33 p.m. June 12, 2014 - Marketwire
Actavis Prices $3.7 Billion of Senior Unsecured Notes 5:19 p.m. June 10, 2014 - PR Newswire - PRF
Fitch Rates New Actavis Bonds 'BBB-'; Outlook Stable 10:55 a.m. June 10, 2014 - BusinessWire - BZX
Actavis Announces Offering of Senior Unsecured Notes 8:48 a.m. June 10, 2014 - PR Newswire - PRF
Actavis Finalizes Agreement Related to Asacol® HD Patent Challenge Litigation 5:54 p.m. June 9, 2014 - PR Newswire - PRF
Forest Laboratories, Inc. Extends Expiration Time of Consent Solicitations to Eliminate Existing Registration Rights Obligations on Certain of its Senior Notes 8:03 a.m. June 9, 2014 - BusinessWire - BZX
Actavis Extends Expiration Time of Offer to Guarantee Certain Forest Laboratories Senior Notes in Connection with Forest Consent Solicitations 8:00 a.m. June 9, 2014 - PR Newswire - PRF
Health Care Sector Equities Scrutiny -- Research on AVANIR Pharma, Zoetis, Actavis, and Mallinckrodt 7:50 a.m. June 3, 2014 - PR Newswire - PRF
New Employers Listed For Annual Life Science Hiring Event 10:45 a.m. June 2, 2014 - PR Newswire - PRF
Actavis Announces Nuvigil® Patent Challenge Settlement 4:05 p.m. May 30, 2014 - PR Newswire - PRF
Enzo Biochem Announces Appointment of James M. O’Brien as Senior VP, Finance 9:01 a.m. May 30, 2014 - BusinessWire - BZX
Breakthrough Innovation for Animal Health, Upcoming Conference Presentations, and New Treatment Options for Patients - Analyst Notes on Merck, Actavis, Celgene, Bristol-Myers Squibb and GSK 5:50 a.m. May 29, 2014 - PR Newswire - PRF
Actavis Confirms Generic Onglyza® Patent Challenge 4:05 p.m. May 27, 2014 - PR Newswire - PRF
Forest Laboratories, Inc. Commences Consent Solicitations to Eliminate Existing Registration Rights Obligations on Certain of its Senior Notes 8:31 a.m. May 22, 2014 - BusinessWire - BZX
Actavis Offers to Guarantee Certain Forest Laboratories Senior Notes in connection with Forest Consent Solicitations 8:30 a.m. May 22, 2014 - PR Newswire - PRF
Study Results, Extension of Supply Agreements, Drug Designations, Senior Level Appointments, and Upcoming Events - Analyst Notes on InterMune, Actavis, Bristol-Myers, AbbVie and Illumina 8:30 a.m. May 22, 2014 - PR Newswire - PRF
Actavis to Present at Goldman Sachs 35th Annual Global Healthcare Conference 2014 8:00 a.m. May 21, 2014 - PR Newswire - PRF
FDA Approvals, Stock Price Updates, and Financial Results Release - Analyst Notes on Pfizer, Actavis, Pharmacyclics, Mallinckrodt and Salix Pharmaceuticals 7:40 a.m. May 16, 2014 - PR Newswire - PRF
(0)
(0)
